Percutaneous tibial nerve stimulation has lasting benefit

July 25, 2013
Percutaneous tibial nerve stimulation has lasting benefit
Percutaneous tibial nerve stimulation with the Urgent PC Neuromodulation System offers sustained overactive bladder symptom improvement after three years of therapy, according to a study published in the June issue of The Journal of Urology.

(HealthDay)—Percutaneous tibial nerve stimulation with the Urgent PC Neuromodulation System offers sustained overactive bladder symptom improvement after three years of therapy, according to a study published in the June issue of The Journal of Urology.

Kenneth M. Peters, M.D., from Beaumont Health System in Royal Oak, Mich., and colleagues assessed long-term outcomes for 50 participants from the Sham Effectiveness in Treatment of Overactive Bladder Symptoms Trial who met the primary effectiveness end point after 12 weekly percutaneous tibial treatments and were enrolled in the Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation (STEP) study. Participants were prescribed a fixed-schedule 14-week tapering protocol followed by a personal treatment plan to maintain overactive bladder symptom improvement.

The researchers found that the 29 patients who completed the 36-month protocol received a median of 1.1 treatments per month after the tapering protocol. At three years, an estimated 77 percent of patients maintained moderate or marked improvement in overactive bladder symptoms. There were significant decreases in median voids per day (12.0 at baseline to 8.7); voids per night (2.7 to 1.7); and urge incontinence episodes per day (3.3 to 0.3). Through three years, all quality-of-life parameters remained significantly improved versus baseline. Two mild treatment-related adverse events were experienced by one patient.

"Most STEP participants with an initial positive response to 12 weekly percutaneous tibial nerve stimulation treatments safely sustained symptom improvement to three years with an average of one treatment per month," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Explore further: The concept of 'overactive bladder' serves better commercial rather than patient interests

More information: Abstract
Full Text

Related Stories

Urodynamic studies affect diagnoses, but not treatment

January 3, 2013

(HealthDay)—Although preoperative urodynamic studies frequently change clinical diagnoses, they rarely lead to changes in the surgical or global treatment plans for women with stress urinary incontinence (UI), according ...

Nerve stimulation helps with overactive bladder

May 30, 2013

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology ...

Recommended for you

Cellphone data can track infectious diseases

August 20, 2015

Tracking mobile phone data is often associated with privacy issues, but these vast datasets could be the key to understanding how infectious diseases are spread seasonally, according to a study published in the Proceedings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.